According to projections, the global recombinant cell culture market is expected to rise significantly from $2.87 billion in 2024 to an astounding $5.81 billion by 2034. With a compound annual growth rate (CAGR) of 7.3%, this impressive rise highlights the critical role that recombinant cell culture technologies play in contemporary biotechnological and medicinal breakthroughs. This...